Patients in Group 3 and Group 4 displayed elevated levels of fasting glucose (Figure 2), fasting insulin (Figure 3), and fasting C-peptide (Figure 4), along with increased values of the HOMA-IR, indicating heightened insulin resistance (Table 2, Supplementary Figure S2). The gene discussed is INS; the disease is Insulin resistance.